Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1

Please use this identifier to cite or link to this item: https://doi.org/10.1136/heartasia-2016-010728

DC Field	Value
dc.title	Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1
dc.contributor.author	Ling, Lieng H
dc.contributor.author	Oh, Vernon MS
dc.date.accessioned	2022-07-06T08:04:43Z
dc.date.available	2022-07-06T08:04:43Z
dc.date.issued	2016-02
dc.identifier.citation	Ling, Lieng H, Oh, Vernon MS (2016-02). Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1. Heart Asia 8 (1) : 28-29. ScholarBank@NUS Repository. https://doi.org/10.1136/heartasia-2016-010728
dc.identifier.issn	17591104
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/228038
dc.publisher	BMJ
dc.source	Elements
dc.type	Article
dc.date.updated	2022-07-06T04:32:07Z
dc.contributor.department	MEDICINE
dc.description.doi	10.1136/heartasia-2016-010728
dc.description.sourcetitle	Heart Asia
dc.description.volume	8
dc.description.issue	1
dc.description.page	28-29
dc.published.state	Published
Appears in Collections:	Elements Staff Publications

File	Description	Size	Format	Access Settings	Version
heartasia-2016-010728.pdf	Published version	447.75 kB	Adobe PDF	CLOSED	Published

Check